Overview

Study to Evaluate the Safety and Efficacy of VIRAZOLE® in Hospitalized Adult Participants With Respiratory Distress Due to COVID-19

Status:
Completed

Trial end date:
2021-08-17

Target enrollment:

Participant gender:

Summary

This study is a Phase 1, open label, non-randomized, two-arm interventional clinical trial to evaluate the safety and efficacy of Virazole® in hospitalized adult patients who have tested positive for COVID-19 and, as a result, have significant respiratory distress (PaO2/FiO2 ratio <300 mmHg).

Phase:

Phase 1

Details

Lead Sponsor:

Bausch Health Americas, Inc.

Treatments:

Ribavirin